Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behçet's disease with and without ocular disease

Ophthalmic Research

Volumn 36, Issue 3, 2004, Pages 177-182

  Aydin, Erdinç ^a,b   Söǧüt, Sadik ^c   Özyurt, Hüseyin ^b   Özuǧurlu, Fikret ^b   Akyol, Ömer ^d  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

^c MUSTAFA KEMAL UNIVERSITY   (Turkey)

^d INONU UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; Glutathione peroxidase; Malondialdehyde; Nitric oxide; Superoxide dismutase

Indexed keywords

GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EYE DISEASE; FEMALE; HUMAN; LABORATORY TEST; MALE; PATHOGENESIS; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ADOLESCENT; ADULT; BEHCET SYNDROME; EYE DISEASES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MALONDIALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

EID: 2342477268     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077332     Document Type: Article

References (31)

1. Lehner I: Immunopathogenesis of Behçet's disease. Ann Méd Interne (Paris) 1999;150:483-487.
2. Hashimoto T, Takeuchi A: Treatment of Behçet's disease. Curr Opin Rheumatol 1992;4:31-34.
3. Chambers JC, Haskard DO, Kooner JS: Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol 2001;37:517-520.
4. Charteris DG, Barton K, McCartney AC, Lightman SL: CD4 lymphocyte involvement in ocular Behçet's disease. Autoimmunity 1992;12:201-216.
5. Köse K, Yazici C, Aşcioglu O: The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behçet's disease. Clin Biochem 2001;34:125-129.
6. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
7. Stichtenoth DO, Frölich JC: Nitric oxide and inflammatory joint diseases. Br J Rheumatol 1998;37:246-257.
8. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am J Physiol 1996;271:3424-3437.
9. Collison MW, Beidler D, Grimm LM, Thomas JA: A comparison of protein S-thiolation (protein mixed-disulfide formation) in heart cells treated with t-butyl hydroperoxide or diamide. Biochim Biophys Acta 1986;885:58-67.
10. Mizushima Y, Inaba G, Mimura Y : Guide for diagnosis of Behçet's disease. Report of Behçet's Disease Research Committee, Japan, Ministry of Health and Welfare, 1987.
11. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407-421.
12. Sun Y, Oberley LW, Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
13. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxides. J Lab Clin Med 1967;70:158-170.
14. Totan Y, Cekic O, Borazan M, Uz E, Sogut S, Akyol O: Plasma malondialdehyde and nitric oxide levels in age related macular degeneration. Br J Ophthalmol 2001;85:1426-1428.
15. Koltuksuz U, Irmak MK, Karaman A, Uz E, Var A, Ozyurt H, Akyol O: Testicular nitric oxide levels after unilateral testicular torsion-distortion in rats pretreated with caffeic acid phenethyl ester. Urol Res 2000;28:360-363.
16. Cortas NK, Wakid NW: Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-1443.
17. Heuson PM, Johnston RB: Tissue injury and inflammation. J Clin Invest 1987;79:669-674.
18. Takeno M, Kariyone A, Yamashita N: Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA B51 transgenic-mice. Arthritis Rheum 1995;38:426-433.
19. Köse K, Doǧan P, Aşcioglu M, Erkiliç K, Asçioglu Ö: Oxidative stress and antioxidant defenses in plasma of patient with Behçet's disease. Tohoku J Exp Med 1995;176:231-248.
20. Freitas JP, Filipe P, Yousefi A, Emerit I, Guerra Rodrigo F: Oxidative stress in Adamantiades-Behçet's disease. Dermatology 1998;197:343-348.
21. Samloska CP, James WD: Superficial thrombophlebitis. II. Secondary hypercoagulable states. J Am Acad Dermatol 1990;23:1-18.
22. Lincoln J, Hoyle CHV, Burnstock G (eds): Nitric Oxide in Health and Disease. Cambridge, Cambridge University Press, 1997, pp 27-41.
23. Farrell AJ, Blake DR: Nitric oxide. Ann Rheum Dis 1996;55:7-20.
24. Kiraz S, Ertenli I, Çalgüneri M, Öztürk MA, Haznedaroglu IC, Altun B, Erman M, Celik I: Interactions of nitric oxide and superoxide dismutase in Behçet's disease. Clin Exp Rheumatol 2001;19:25-29.
25. Wang LM, Kitteringham N, Mineshita S, Wang JZ, Nomura Y, Koike Y, Miyashita E: The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behçet's disease. Arch Dermatol Res 1997;298:444-447.
26. Tüzün A, Aydin A, Turan M: Erythrocyte antioxidant activity and trace element levels in Behçet's disease. Biol Trace Elem Res 1998;64:169-174.
27. Blum J, Fridovich I: Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985;240:500-508.
28. Arshad MAQ, Bhadra S, Cohen RM, Subbiah MTR: Plasma lipoprotein peroxidation potential: A test to evaluate individual susceptibility. Clin Chem 1991;37:1756-1758.
29. Belfort R Jr, Moura NC, Mendes NF: T and B-lymphocytes in the aqueous humor of patients with uveitis. Arch Ophthalmol 1982;100:465-467.
30. Kahan A, Hamzaoui K, Ayed K: Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. J Rheumatol 1992;19:742-746.
31. Tugal-Tutkun I, Urgancioglu M, Foster CS: Immunopathologic study of the conjunctiva in patients with Behçet disease. Ophthalmology 1995;102:1660-1668.